Jason Industries to Participate in Deutsche Bank Leveraged Finance Conference
Sep 26, 2016 12:01 pm UTC| Business
MILWAUKEE, Sept. 26, 2016 -- Jason Industries, Inc. (Nasdaq:JASN) (Nasdaq:JASNW) (the "Company" or "Jason") today announced that it will participate in the Deutsche Bank 2016 Leveraged Finance Conference at The...
Jason Industries to Participate in Deutsche Bank Leveraged Finance Conference
Sep 26, 2016 12:01 pm UTC| Business
MILWAUKEE, Sept. 26, 2016 -- Jason Industries, Inc. (Nasdaq:JASN) (Nasdaq:JASNW) (the "Company" or "Jason") today announced that it will participate in the Deutsche Bank 2016 Leveraged Finance Conference at The...
Skullcandy® Expands Sport Performance Line with Method® Wireless Earbuds
Sep 26, 2016 12:01 pm UTC| Business
PARK CITY, Utah, Sept. 26, 2016 -- Skullcandy, Inc. (NASDAQ:SKUL), the performance and lifestyle audio brand founded at the intersection of music, sports, technology, and creative culture, is expanding its sports...
Skullcandy® Expands Sport Performance Line with Method® Wireless Earbuds
Sep 26, 2016 12:01 pm UTC| Business
PARK CITY, Utah, Sept. 26, 2016 -- Skullcandy, Inc. (NASDAQ:SKUL), the performance and lifestyle audio brand founded at the intersection of music, sports, technology, and creative culture, is expanding its sports...
Vericel to Present at 2016 Cell & Gene Meeting on the Mesa
Sep 26, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Sept. 26, 2016 -- Vericel Corporation (Nasdaq:VCEL), a leading developer of autologous cellular therapies for the treatment of severe diseases and conditions, today announced that Nick Colangelo,...
Vericel to Present at 2016 Cell & Gene Meeting on the Mesa
Sep 26, 2016 12:01 pm UTC| Business
CAMBRIDGE, Mass., Sept. 26, 2016 -- Vericel Corporation (Nasdaq:VCEL), a leading developer of autologous cellular therapies for the treatment of severe diseases and conditions, today announced that Nick Colangelo,...
Sep 26, 2016 12:01 pm UTC| Business
TEL AVIV, Israel, Sept. 26, 2016 -- Bioblast Pharma Ltd. (Nasdaq:ORPN), a clinical-stage, orphan disease-focused biotechnology company, today announced that Zohar Argov, MD, Special Medical Advisor to the Executive...